Results of a prospective study of patients with breast or prostate cancer demonstrate the impact of taxane-based chemotherapy on quality of life.
In an evaluation of SEER-Medicare data, researchers sought to determine the benefits of extreme use of monitoring in patients with metastatic prostate cancer at the end of life on survival outcomes, quality of life, and costs.
ADT recipients reported worse subjective sleep disturbance, researchers found.
According to the FDA, the drug approval is the first to use the end point of metastasis-free survival.
Aggressive therapy does not appear to be more beneficial than conservative androgen deprivation therapy alone, according to a study.
Researchers sought to determine the effect single PSA testing had on prostate cancer diagnosis, mortality, and all-cause mortality.
At $225 million per system, the precision of proton beam radiotherapy is not necessarily overshadowing its high costs. Yet ongoing studies seek to determine how this technology fits into current treatment regimens for prostate, breast, and other cancers.
Long-distance travel was more strongly associated with definitive prostate SBRT use, researchers found.
SPARTAN phase 3 study shows that apalutamide prolongs metastasis-free survival and time to symptomatic progression compared with placebo among men with nonmetastatic CRPC.
Those with pancreatic adenocarcinoma and a personal history of another cancer associated with hereditary breast and ovarian cancer or Lynch syndrome may be more likely to carry germline mutations.
Researchers present findings of a comparison of daily image-guided radiotherapy (IGRT) vs a weekly regimen in patients with N0 localized prostate cancer at the 2018 GU Cancers Symposium.
Rates of erectile dysfunction and urinary incontinence at 1, 2, and 3 years after radical surgery are not higher among men who have multiple prostate biopsies while on active surveillance for prostate cancer.
Propensity score-matched study compared adjuvant radiotherapy with surveillance and early-salvage radiotherapy after prostatectomy in men with prostate cancer.
Data from the phase 3 SPARTAN trial prompted the FDA's Priority Review designation for apalutamide.
In a small but meaningful number of patients, Gleason pattern 4 disease missed by MRI and systematic biopsy is present outside the focal ablation zone.
Hypogonadal men who received testosterone replacement therapy had a lower incidence of prostate cancer than those who did not, and their cancers were less severe.
The impact of prostate cancer treatment is well documented; however, in this study, researchers sought to determine the effect on health-related quality of life for patients from diagnosis through treatment planning to initiation of treatment.
An analysis of an intervention arm of the PLCO Cancer Screening Trial evaluated the risk of prostate cancer relative to dietary consumption of isoflavones, a dietary compound found in some plant foods.
A survey followed up with an assessment via validated tools determined that patients with prostate cancer who experienced regret after radical prostatectomy were more susceptible to depression-associated sleep disorders.
The risk of cardiovascular disease such as heart failure, arrhythmias, and conduction disorders are greater in men with localized prostate cancer who were treated with androgen deprivation therapy.
Osteoporosis medications were found to reduce bone mineral density loss and risk of fracture in men with nonmetastatic prostate cancer being treated with androgen-deprivation therapy.
A smaller dose of cabazitaxel (C20) is noninferior to a larger dose (C25) in the post-docetaxel treatment of mCRPC.
Cabazitaxel does not prolong OS in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer compared with the first-line chemotherapy agent docetaxel.
Meta-analysis of data from more than 50 studies reaffirms that vasectomy is not associated with increased risk of prostate cancer.
Study found taller and heavier males were more likely to develop prostate cancer, and they are also more likely to die of the disease.
Study results show that patients with prostate cancer express treatment decision regret, with concerns regarding sexual function, bowel function, and PSA most commonly associated with regret.
How the body metabolizes next-generation anti-androgen agents affects their anti-tumor activity in the treatment of prostate cancer.
Prostate-specific molecular imaging, such as PET and CT, can detect more cancer and improve patient care.
A survey of men with prostate cancer revealed that treatment-related factors impact treatment decisions differently in black men compared with white men.
Prehabilitation before initiating ADT in older men with prostate cancer may improve functioning, even in men on short-term ADT.
Sign Up for Free e-newsletters
- Physical Inactivity Linked With Increased Risk of Hodgkin, Non-Hodgkin Lymphoma
- Challenges for Young Adult Couples Facing a Cancer Diagnosis
- Progression-Free Survival Extended With PANEX Protocol in R/R Multiple Myeloma
- Following ACS Guidelines Shown to Improve Outcomes for Colon Cancer Survivors
- National Cancer Drug Shortages Unknown to Many Patients
- Letter-Writing Project Communicates Care Wishes to Healthcare Team, Family
- Pivot Nurse Improves Patients' Navigation Through Lung Cancer Care
- Long-term Carfilzomib May Be Safe, Effective In Relapsed Multiple Myeloma
- Palliative Sedation a Valid Option for Refractory Symptoms in End-stage Cancer
- Testicular Cancer Treatment May Increase Risk for Heart Disease in Survivors
- Spotlight on Triptorelin in the Treatment of Premenopausal Women with Early-Stage Breast Cancer
- Redefining Prognosis for Hematologic Cancers in Older Adults by Age
- Outcomes for Elderly With Hematologic Cancers Effected by Cognitive Impairments
- Evolving Role of Radiation Therapy in the Treatment of Mesothelioma
- FDA Approves Fostamatinib for ITP After Insufficient Response to Previous Treatment
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|